We are live on ! Find out more
HCMT

Highland Capital Management (Texas) Portfolio holdings

AUM $39M
This Fund
S&P 500
This Quarter Est. Return
-1.86%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.71B
AUM Growth
+$105M
Cap. Flow
+$158M
Cap. Flow %
9.22%
Top 10 Hldgs %
44.34%
Holding
408
New
98
Increased
45
Reduced
65
Closed
96

Top Buys

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$27.6M
2
NXRT
NexPoint Residential Trust
NXRT
+$23.8M
3
FTNT icon
Fortinet
FTNT
+$22.4M
4
ET icon
Energy Transfer Partners
ET
+$15.8M
5
BMY icon
Bristol-Myers Squibb
BMY
+$14.8M

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$10.6M
2
VST icon
Vistra
VST
+$7.46M
3
AAL icon
American Airlines Group
AAL
+$7.31M
4
MLNX
Mellanox Technologies, Ltd.
MLNX
+$6.27M
5
PRTK
Paratek Pharmaceuticals, Inc.
PRTK
+$6.01M

Sector Composition

Rank Sector Weight
1 Energy 13.75%
2 Technology 13.1%
3 Utilities 12%
4 Real Estate 8.78%
5 Healthcare 7.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SMTA
201
DELISTED
Spirit MTA REIT Common Shares of Beneficial Interest
SMTA
$1.11M 0.06%
132,533
– –
ABBV icon
202
AbbVie
ABBV
$435B
$1.09M 0.06%
15,000
+10,000
+200% +$786K
BKD icon
203
Brookdale Senior Living
BKD
$3.4B
$1.08M 0.06%
150,525
– –
ITUB icon
204
Itaú Unibanco
ITUB
$87.5B
$1.08M 0.06%
158,048
– –
SSFN
205
DELISTED
Stewardship Financial Corp
SSFN
$1.07M 0.06%
+69,462
New +$762K
AQ
206
DELISTED
Aquantia Corp. Common Stock
AQ
$1.07M 0.06%
+82,095
New +$959K
XRX icon
207
Xerox
XRX
$425M
$1.06M 0.06%
+30,000
New +$1M
AMBR
208
DELISTED
Amber Road Inc
AMBR
$1.06M 0.06%
+81,244
New +$912K
MOH icon
209
Molina Healthcare
MOH
$10.3B
$1.05M 0.06%
7,363
-2,200
-23% -$301K
ZAYO
210
DELISTED
Zayo Group Holdings, Inc.
ZAYO
$1.04M 0.06%
31,595
– –
ANSS
211
DELISTED
Ansys
ANSS
$1.02M 0.06%
+5,000
New +$953K
SCHW
212
Charles Schwab
SCHW
$187B
$1M 0.06%
+25,000
New +$1.09M
ELV icon
213
Elevance Health
ELV
$85.5B
$988K 0.06%
3,500
+1,500
+75% +$410K
GBT
214
DELISTED
Global Blood Therapeutics, Inc.
GBT
$921K 0.05%
17,500
– –
HFRO
215
Highland Opportunities and Income Fund
HFRO
$407M
$900K 0.05%
64,998
– –
EYPT icon
216
EyePoint Inc
EYPT
$1.2B
$894K 0.05%
54,500
– –
RARE icon
217
Ultragenyx Pharmaceutical
RARE
$2.55B
$880K 0.05%
13,855
– –
DTIL icon
218
Precision BioSciences
DTIL
$207M
$861K 0.05%
2,167
– –
EBIX
219
DELISTED
Ebix Inc
EBIX
$859K 0.05%
17,100
– –
VKTX icon
220
Viking Therapeutics
VKTX
$4B
$851K 0.05%
102,492
– –
MAC icon
221
Macerich
MAC
$6.92B
$850K 0.05%
25,380
– –
FG
222
DELISTED
FGL Holdings Ordinary Shares
FG
$840K 0.05%
100,000
– –
C icon
223
Citigroup
C
$226B
$833K 0.05%
11,900
-3,100
-21% -$207K
MLPX icon
224
Global X MLP & Energy Infrastructure ETF
MLPX
$3.5B
$832K 0.05%
21,433
– –
AXNX
225
DELISTED
Axonics, Inc. Common Stock
AXNX
$819K 0.05%
20,000
– –
7 8
9
10 11

Similar funds

DHRFI
DCM Hybrid RMB Fund International Menlo Park, California $35.3M AUM
TG
TRV GP Boston, Massachusetts $18.9M AUM 541.67% 1-Year Est. Return
QVT
Quantitative Value Technologies Overland Park, Kansas $60.7M AUM
KA
KSL Advisors Denver, Colorado $16.1M AUM
AC
Aperimus Capital Marina Del Rey, California $62.2M AUM 47.35% 1-Year Est. Return
FRGX
First Reserve GP XII Stamford, Connecticut $3.16M AUM 24.66% 1-Year Est. Return
SA
Silversage Advisors Irvine, California $2.41M AUM 46.55% 1-Year Est. Return
YECIP
YT Extraction Co Investment Partners New York $1.73M AUM

Highland Capital Management (Texas)'s Q2 2019 Portfolio in Review

As of Q2 2019, Highland Capital Management (Texas) held 408 positions worth $1.71B, up 6.6% from $1.6B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Highland Capital Management (Texas) deployed $158M of net new capital in Q2 2019, opening 98 new positions and adding to 45 existing holdings. Its largest new stake was Bristol-Myers Squibb: 318,200 shares worth $14.4M.

By sector, the portfolio is most concentrated in Energy at 14% of assets, up from 12% a quarter earlier, followed by Technology and Utilities.

On the sell side, the largest reduction was Intel, an estimated $10.6M trimmed.

  • Highland Capital Management (Texas)'s largest Q2 2019 buy was Bristol-Myers Squibb: 318,200 shares worth $14.4M.
  • Highland Capital Management (Texas) added most to Pioneer Natural Resource Co. in Q2 2019, an estimated $27.6M increase.
  • Highland Capital Management (Texas)'s biggest Q2 2019 reduction was Intel, cutting an estimated $10.6M.
  • Highland Capital Management (Texas) fully exited Mellanox Technologies, Ltd. in Q2 2019, selling an estimated $6.27M.
  • Highland Capital Management (Texas)'s ten largest holdings make up 44% of its $1.71B portfolio in Q2 2019.
  • Highland Capital Management (Texas) opened 98 new positions and closed 96 in Q2 2019.
  • Highland Capital Management (Texas)'s portfolio value rose 6.6% quarter-over-quarter to $1.71B.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2019, filed 14 Aug 2019.